A crossover study of the combination therapy of metformin and exenatide or biphasic insulin aspart 30 in overweight or obese patients newly diagnosed with type 2 diabetes mellitus

Combination Therapy ◽

Insulin Aspart ◽

Obese Patients ◽

Newly Diagnosed ◽

Biphasic Insulin ◽

Addition of biphasic insulin aspart 30 to rosiglitazone in type 2 diabetes mellitus that is poorly controlled with glibenclamide monotherapy

10.1016/s0149-2918(03)90095-6 ◽

2003 ◽

Vol 25 (12) ◽

pp. 3109-3123 ◽

Cited By ~ 17

Author(s):

Itamar Raz ◽

Ulrik Mouritzen ◽

Julius Vaz ◽

Tommy Hershkovitz ◽

Julio Wainstein ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Insulin Aspart ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Addition of biphasic insulin aspart 30 to optimized metformin and pioglitazone treatment of type 2 diabetes mellitus: The ACTION Study (Achieving Control Through Insulin plus Oral ageNts)

Diabetes Obesity and Metabolism ◽

10.1111/j.1463-1326.2007.00796.x ◽

2009 ◽

Vol 11 (1) ◽

pp. 27-32 ◽

Cited By ~ 24

Author(s):

P. Raskin ◽

G. Matfin ◽

S. L. Schwartz ◽

L. Chaykin ◽

P.-L. Chu ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Insulin Aspart ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Biphasic Insulin Aspart 30 ◽

Oral Agents ◽

Pioglitazone Treatment

Twice-daily biphasic insulin aspart 30 versus biphasic human insulin 30: A double-blind crossover study in adults with type 2 diabetes mellitus

10.1016/s0149-2918(02)85129-3 ◽

2002 ◽

Vol 24 (4) ◽

pp. 530-539 ◽

Cited By ~ 64

Author(s):

Paul T. McSorley ◽

Patrick M. Bell ◽

Lisbeth Vestergård Jacobsen ◽

Allan Kristensen ◽

Anders Lindholm

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Insulin Aspart ◽

Double Blind ◽

Biphasic Insulin ◽

Biphasic Insulin Aspart 30 ◽

Blind Crossover Study ◽

Double Blind Crossover Study

Efficacy and safety of three-times-daily versus twice-daily biphasic insulin aspart 30 in patients with type 2 diabetes mellitus inadequately controlled with basal insulin combined with oral antidiabetic drugs

Diabetes Research and Clinical Practice ◽

10.1016/j.diabres.2019.02.023 ◽

2019 ◽

Vol 150 ◽

pp. 158-166 ◽

Cited By ~ 1

Author(s):

Wenying Yang ◽

Canan Ersoy ◽

Guixia Wang ◽

Shandong Ye ◽

Jun Liu ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Insulin Aspart ◽

Efficacy And Safety ◽

Oral Antidiabetic Drugs ◽

Biphasic Insulin ◽

Oral Antidiabetic ◽

Risk for nocturnal hypoglycemia with biphasic insulin aspart 30 compared with biphasic human insulin 30 in adults with type 2 diabetes mellitus: A meta-analysis

10.1016/j.clinthera.2009.08.011 ◽

2009 ◽

Vol 31 (8) ◽

pp. 1641-1651 ◽

Cited By ~ 39

Author(s):

Jaime A. Davidson ◽

Andreas Liebl ◽

Jens S. Christiansen ◽

Greg Fulcher ◽

Robert J. Ligthelm ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Human Insulin ◽

Insulin Aspart ◽

Meta Analysis ◽

Nocturnal Hypoglycemia ◽

Biphasic Insulin ◽

Randomized, multinational, open-label, 2-period, crossover comparison of biphasic insulin aspart 30 and biphasic insulin lispro 25 and pen devices in adult patients with type 2 diabetes mellitus

10.1016/s0149-2918(04)90055-0 ◽

2004 ◽

Vol 26 (4) ◽

pp. 531-540 ◽

Cited By ~ 67

Author(s):

L NISKANEN

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Insulin Lispro ◽

Insulin Aspart ◽

Open Label ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Initiating or Switching to Biphasic Insulin Aspart 30/70 Therapy in Subjects with Type 2 Diabetes Mellitus. An Observational Study

The Review of Diabetic Studies ◽

10.1900/rds.2008.5.154 ◽

2008 ◽

Vol 5 (3) ◽

pp. 154-162 ◽

Cited By ~ 5

Author(s):

Leif Breum ◽

Thomas Almdal ◽

Pia Eiken ◽

Per Lund ◽

Erik Christiansen

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Observational Study ◽

Insulin Aspart ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Initiation of biphasic insulin aspart 30/70 in subjects with type 2 diabetes mellitus in a largely primary care-based setting in Sweden

Primary Care Diabetes ◽

10.1016/j.pcd.2011.02.003 ◽

2011 ◽

Vol 5 (2) ◽

pp. 89-94 ◽

Cited By ~ 6

Author(s):

Kerstin Berntorp ◽

Mattias Haglund ◽

Sara Larsen ◽

Ann Petruckevitch ◽

Mona Landin-Olsson

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Primary Care ◽

Insulin Aspart ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

PDB11 CLINICAL AND COST-EFFECTIVENESS OF BIPHASIC INSULIN ASPART 30 ONCE OR TWICE DAILY VERSUS INSULIN GLARGINE IN TYPE 2 DIABETES MELLITUS: A MODELING ANALYSIS IN THE CHINESE SETTING

Value in Health ◽

10.1016/s1098-3015(11)73186-2 ◽

2010 ◽

Vol 13 (7) ◽

pp. A528

Author(s):

JL Palmer ◽

A Beaudet ◽

J White ◽

J Plun-Favreau ◽

J Smith-Palmer

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Cost Effectiveness ◽

Insulin Glargine ◽

Insulin Aspart ◽

Biphasic Insulin ◽

Modeling Analysis ◽

IMPROVE™ observational study of biphasic insulin aspart 30/70 in patients with Type 2 diabetes mellitus

Expert Review of Endocrinology & Metabolism ◽

10.1586/eem.10.31 ◽

2010 ◽

Vol 5 (4) ◽

pp. 507-516 ◽

Cited By ~ 5

Author(s):

Ryuzo Kawamori ◽

Paul Valensi

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Observational Study ◽

Insulin Aspart ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽